SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
SEC Accession No. 0001193125-24-034118
Filing Date
2024-02-13
Accepted
2024-02-13 18:59:26
Documents
2
Group Members
BCIP LIFE SCIENCES ASSOCIATES, LPBCLS II EQUITY OPPORTUNITIES, LP

Document Format Files

Seq Description Document Type Size
1 SC 13G/A d749338dsc13ga.htm SC 13G/A 86919
2 EX-99.A d749338dex99a.htm EX-99.A 11799
  Complete submission text file 0001193125-24-034118.txt   100439
Mailing Address 35 CAMBRIDGE PARK DRIVE CAMBRIDGE MA 02140
Business Address 35 CAMBRIDGE PARK DRIVE CAMBRIDGE MA 02140 617-744-1340
Syros Pharmaceuticals, Inc. (Subject) CIK: 0001556263 (see all company filings)

IRS No.: 453772460 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-89552 | Film No.: 24630941
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 200 CLARENDON STREET BOSTON MA 02116
Business Address 200 CLARENDON STREET BOSTON MA 02116 6175162000
Bain Capital Life Sciences Fund II, L.P. (Filed by) CIK: 0001773187 (see all company filings)

IRS No.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: SC 13G/A